You can't like your own messages.

dondet

Don Detweiler
Lexington, MA

Joined Apr 18, 2010

BioTech trader - primarily on runup plays around FDA decision and clinical trial dates.

dondet
$ALXA Investor Investigation over potential Security Law Violations, misleading statements http://t.co/zRsDPYos

May. 24 at 9:49 AM

from Twitter
dondet
$VTUS my only green position this AM; top-line results for Diltiazem Topical Cream (VEN 307) to be released this month

May. 9 at 10:16 AM

from Twitter
1

dondet
$ALXA officers & directors may have violated federal securities laws http://t.co/IKMfh4ee

May. 7 at 10:39 AM

from Twitter
dondet
$ALXA heavy options volume, 98% calls http://t.co/dOuLBJUs

May. 4 at 4:52 PM

from Twitter
dondet
$ALXA conf call: reverse split "not on our to-do list" http://t.co/ItuSQfYK response letter possible by EOY

May. 4 at 4:41 PM

from Twitter
dondet
$YMI makes bid to enter Myelofibrosis (MF) mkt currently dominated by $INCY http://t.co/iqSgj5Vv http://t.co/1YBNAbPt

May. 4 at 2:57 PM

from Twitter
dondet
$ALXA confident mfg problem will be resolved http://t.co/evv7KITo mfg issues likely involve the device used to deliver the inhaled drug

May. 4 at 12:08 PM

from Twitter
dondet
$ALXA in @$0.44 - CRL mfg & labeling issuse only; no new data or trials; should be quick turnaround for ADASUVE

May. 4 at 10:14 AM

from Twitter
dondet
$RGEN better profit reported http://t.co/E28IWk82 not helping pps today!

May. 3 at 11:04 AM

from Twitter
dondet
$MSHL Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer http://t.co/Hd25623J

May. 2 at 10:49 AM

from Twitter
dondet
$CLDX clerical error @ASCO like Gingrich & Perry screwup getting on VA ballot in Dec. - no change in runup potential; adding shs here @$4.28

May. 2 at 10:09 AM

from Twitter
dondet
$ACAD 1Q12 earnings May 8 http://t.co/JA6mzp0A

May. 1 at 2:37 PM

from Twitter
1

dondet
$AMRN SAC Capital positioning for takeover? http://t.co/tX4fK5kF 13D filing notifying that it had raised its stake in Amarin from 4% to 5.3%

Apr. 27 at 12:27 PM

from Twitter
dondet
$NEPT taking 20% profit @$3.50 on today's spike; my most worrisome prob w/this stock is that BioMedReports is pumping it like crazy

Apr. 26 at 3:42 PM

from Twitter
dondet
$NEPT Rodman & Renshaw resumes the stock at an Outperform and assigns it a target price of $7 http://t.co/tdfQqaPZ

Apr. 26 at 1:11 PM

from Twitter

Follow dondet on StockTwits!

Follow investors and traders that match your style and get a personalized stream of news, charts, and ideas.

81 Followers

Trader Profile

Experience: Intermediate
Assets Traded: Equities, Options
Approach: Growth
Holding Period: Swing Trader

dondet

Add Twitter Connection

Add Facebook Connection

Add LinkedIn Connection

Follow dondet on StockTwits!

Trader Profile

dondet

Add Twitter Connection

Add Facebook Connection

Add LinkedIn Connection

Follow dondet on StockTwits!

Trader Profile

Sign in to StockTwits X

Sign in

Sign up using:

Sign in to StockTwits X

Sign up X

Join StockTwits

Sign up using:

Sign up
using:

Sign up
using: